Wealthfront Advisers LLC Buys New Shares in Teladoc Health, Inc. (NYSE:TDOC)
Wealthfront Advisers LLC Buys New Shares in Teladoc Health, Inc. (NYSE:TDOC)
Wealthfront Advisers LLC bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 81,183 shares of the health services provider's stock, valued at approximately $2,696,000. Wealthfront Advisers LLC owned 0.05% of Teladoc Health as of its most recent SEC filing.
Wealthront Advisers LLC在第二季度购买了Teladoc Health,Inc.(纽约证券交易所代码:TDOC-GET Rating)的新股,该公司在最近提交给美国证券交易委员会的文件中说。该基金购买了这家医疗服务提供商的81,183股票,价值约2,696,000美元。截至最近提交的美国证券交易委员会申请文件,Wealthfront Advisers LLC拥有Teladoc Health 0.05%的股份。
Other institutional investors also recently modified their holdings of the company. DB Wealth Management Group LLC acquired a new position in Teladoc Health during the first quarter worth $25,000. McCarthy Asset Management Inc. acquired a new position in Teladoc Health during the first quarter worth $25,000. Oliver Lagore Vanvalin Investment Group acquired a new position in Teladoc Health during the first quarter worth $27,000. City State Bank acquired a new position in Teladoc Health during the fourth quarter worth $27,000. Finally, GoalVest Advisory LLC acquired a new position in Teladoc Health during the first quarter worth $31,000. Institutional investors and hedge funds own 92.46% of the company's stock.
其他机构投资者最近也调整了对该公司的持股。DB Wealth Management Group LLC在第一季度收购了Teladoc Health的一个新头寸,价值2.5万美元。麦卡锡资产管理公司在第一季度收购了Teladoc Health的一个新头寸,价值2.5万美元。Oliver LaGore Vanvalin投资集团在第一季度收购了Teladoc Health的一个新头寸,价值2.7万美元。城市国家银行在第四季度收购了Teladoc Health的一个新头寸,价值2.7万美元。最后,GoalVest Consulting LLC在第一季度收购了Teladoc Health的一个新头寸,价值3.1万美元。机构投资者和对冲基金持有该公司92.46%的股票。
Analyst Upgrades and Downgrades
分析师升级和下调评级
TDOC has been the topic of several research reports. Truist Financial initiated coverage on shares of Teladoc Health in a report on Wednesday, September 7th. They set a "hold" rating and a $35.00 price objective on the stock. Piper Sandler lowered their price objective on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating on the stock in a report on Thursday, July 28th. Royal Bank of Canada lowered their target price on shares of Teladoc Health from $53.00 to $35.00 in a report on Wednesday. Cowen downgraded shares of Teladoc Health from an "outperform" rating to a "market perform" rating and lowered their target price for the company from $58.00 to $34.00 in a report on Tuesday, August 2nd. Finally, Stifel Nicolaus lowered their target price on shares of Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th. Two analysts have rated the stock with a sell rating, twenty-four have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $64.13.
TDOC一直是几份研究报告的主题。Truist Financial在9月7日星期三的一份报告中启动了对Teladoc Health股票的报道。他们为该股设定了“持有”评级和35.00美元的目标价。派珀·桑德勒在7月28日周四的一份报告中将Teladoc Health的股票目标价从42.00美元下调至40.00美元,并对该股设定了“增持”评级。加拿大皇家银行在周三的一份报告中将Teladoc Health的目标价从53.00美元下调至35.00美元。在8月2日周二的一份报告中,Cowen将Teladoc Health的股票评级从“跑赢大盘”下调至“市场表现”,并将该公司目标价从58.00美元下调至34.00美元。最后,Stifel Nicolaus在7月28日星期四的一份报告中将Teladoc Health的目标股价从36.00美元下调至30.00美元。两名分析师对该股的评级为卖出,24名分析师对该股给予持有评级,五名分析师对该股给予买入评级。根据MarketBeat.com的数据,该股目前的平均评级为持有,共识目标价为64.13美元。
Insider Buying and Selling
内幕买卖
Teladoc Health Stock Down 3.4 %
Teladoc Health股票下跌3.4%
TDOC stock opened at $25.35 on Friday. The firm has a 50 day moving average of $33.43 and a 200-day moving average of $41.33. Teladoc Health, Inc. has a 12 month low of $25.33 and a 12 month high of $156.82. The company has a debt-to-equity ratio of 0.25, a quick ratio of 3.22 and a current ratio of 3.38.
上周五,TDOC股价开盘报25.35美元。该公司的50日移动均线切入位在33.43美元,200日移动均线切入位在41.33美元。Teladoc Health,Inc.的12个月低点为25.33美元,12个月高位为156.82美元。该公司的负债权益比率为0.25,速动比率为3.22,流动比率为3.38。
Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share for the quarter, topping analysts' consensus estimates of ($0.71) by $0.27. The business had revenue of $592.38 million for the quarter, compared to analyst estimates of $586.86 million. Teladoc Health had a negative net margin of 441.94% and a negative return on equity of 2.04%. Equities analysts expect that Teladoc Health, Inc. will post -1.54 EPS for the current fiscal year.
Teladoc Health(纽约证券交易所代码:TDOC-GET Rating)最近一次公布收益结果是在7月27日星期三。这家医疗服务提供商公布了该季度每股收益(0.44美元),比分析师普遍预期的(0.71美元)高出0.27美元。该业务本季度营收为5.9238亿美元,而分析师预期为5.8686亿美元。Teladoc Health的净利润率为负441.94%,净资产回报率为负2.04%。股票分析师预计,Teladoc Health,Inc.本财年每股收益将达到1.54美元。
About Teladoc Health
关于Teladoc Health
(Get Rating)
(获取评级)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Teladoc Health,Inc.在美国和国际上提供虚拟医疗服务。该公司提供一系列服务和解决方案,涵盖非紧急、间歇性、慢性和复杂的医疗状况,包括糖尿病、高血压、慢性肾脏疾病、癌症、充血性心力衰竭和精神健康状况。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Thor Industries Hammers Out A Bottom
- 免费获取StockNews.com关于Teladoc Health(TDOC)的研究报告
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat:回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何?
- 雷神工业走出谷底
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Get Rating).
想看看其他对冲基金持有TDOC的情况吗?访问HoldingsChannel.com获取Teladoc Health,Inc.(纽约证券交易所代码:TDOC-GET Rating)的最新13F文件和内幕交易信息。
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受Teladoc健康日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Teladoc Health和相关公司的最新新闻和分析师评级的每日简要摘要。